Chemotherapy response evaluation with FDG–PET in patients with colorectal cancer

Even-Sapir, 2004, Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection, Radiology, 232, 815, 10.1148/radiol.2323031065

Bipat, 2005, Colorectal liver metastases: CT, MR imaging, and PET for diagnosis—meta-analysis, Radiology, 237, 123, 10.1148/radiol.2371042060

Kinkel, 2002, Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis, Radiology, 224, 748, 10.1148/radiol.2243011362

Wiering, 2005, The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases, Cancer, 104, 2658, 10.1002/cncr.21569

Flamen, 2001, Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: the utility of positron emission tomography (PET), Eur J Cancer, 37, 862, 10.1016/S0959-8049(01)00049-1

Ito, 1992, Recurrent rectal cancer and scar: differentiation with PET and MR imaging, Radiology, 182, 549, 10.1148/radiology.182.2.1732979

Votrubova, 2006, The role of FDG-PET/CT in the detection of recurrent colorectal cancer, Eur J Nucl Med Mol Imaging, 33, 779, 10.1007/s00259-006-0072-z

Ruers, 2002, Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study, J Clin Oncol, 20, 388, 10.1200/JCO.20.2.388

Pauwels, 1998, The mechanism of accumulation of tumour-localising radiopharmaceuticals, Eur J Nucl Med, 25, 277, 10.1007/s002590050229

de Geus-Oei, 2006, Comparison of image-derived and arterial input functions for estimating the rate of glucose metabolism in therapy-monitoring 18F-FDG PET studies, J Nucl Med, 47, 945

Greuter, 2003, Measurement of 18F-FDG concentrations in blood samples: comparison of direct calibration and standard solution methods, J Nucl Med Technol, 31, 206

Patlak, 1983, Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data, J Cereb Blood Flow Metab, 3, 1, 10.1038/jcbfm.1983.1

Hoekstra, 2002, Methods to monitor response to chemotherapy in non-small cell lung cancer with 18F-FDG PET, J Nucl Med, 43, 1304

Young, 1999, Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group, Eur J Cancer, 35, 1773, 10.1016/S0959-8049(99)00229-4

Therasse, 2000, New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada, J Natl Cancer Inst., 92, 205, 10.1093/jnci/92.3.205

Westerterp, 2007, Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters, Eur J Nucl Med Mol Imaging, 34, 392, 10.1007/s00259-006-0224-1

Amthauer, 2004, Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology, Eur J Nucl Med Mol Imaging, 31, 811, 10.1007/s00259-003-1453-1

Denecke, 2005, Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: is there a benefit in using functional imaging?, Eur Radiol, 15, 1658, 10.1007/s00330-005-2658-4

Guillem, 2000, Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography, Dis Colon Rectum, 43, 18, 10.1007/BF02237238

Guillem, 2004, Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer, J Am Coll Surg, 199, 1, 10.1016/j.jamcollsurg.2004.02.024

Calvo, 2004, 18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation, Int J Radiat Oncol Biol Phys, 58, 528, 10.1016/j.ijrobp.2003.09.058

Schiepers, 1999, The effect of preoperative radiation therapy on glucose utilization and cell kinetics in patients with primary rectal carcinoma, Cancer, 85, 803, 10.1002/(SICI)1097-0142(19990215)85:4<803::AID-CNCR7>3.0.CO;2-T

Cascini, 2006, 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer, J Nucl Med, 47, 1241

Langenhoff, 2002, Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study, J Clin Oncol, 20, 4453, 10.1200/JCO.2002.12.134

Joosten, 2005, Cryosurgery and radiofrequency ablation for unresectable colorectal liver metastases, Eur J Surg Oncol, 31, 1152, 10.1016/j.ejso.2005.07.010

Donckier, 2003, [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases, J Surg Oncol, 84, 215, 10.1002/jso.10314

Blokhuis, 2004, Results of radio frequency ablation of primary and secondary liver tumors: long-term follow-up with computed tomography and positron emission tomography-18F-deoxyfluoroglucose scanning, Scand J Gastroenterol Suppl, 93, 10.1080/00855920410014623

Findlay, 1996, Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil, J Clin Oncol, 14, 700, 10.1200/JCO.1996.14.3.700

Bender, 1999, Possible role of FDG-PET in the early prediction of therapy outcome in liver metastases of colorectal cancer, Hybridoma, 18, 87, 10.1089/hyb.1999.18.87

Dimitrakopoulou-Strauss, 2003, PET-FDG as predictor of therapy response in patients with colorectal carcinoma, Q J Nucl Med, 47, 8

Dimitrakopoulou-Strauss, 2004, Prognostic aspects of 18F-FDG PET kinetics in patients with metastatic colorectal carcinoma receiving FOLFOX chemotherapy, J Nucl Med, 45, 1480